Trial Site Detail
Drug: |
Hydroxychloroquine + Sorafenib |
|||
|---|---|---|---|---|
Trial: |
Oral Hydroxychloroquine Plus Oral Sorafenib to Treat Patients With Refractory or Relapsed Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
|||
Cancer Therapy and Research Center7979 Wurzbach Rd. |
Principal Investigator: |
Tyler Curiel, MD, MPH |
|---|---|
Contact: |
Epp Goodwin 210-450-5798 onctrial@idd.org |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Cancer Therapy and Research Center Website: |
http://www.ctrc.net/research/clinicalname.cfm |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.